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The scale-up of HIV services in sub-Saharan Africa has catalyzed the development of highly effective chronic care systems. The
strategies, systems, and tools developed to support life-long HIV care and treatment are locally owned contextually appropriate
resources, many of which could be adapted to support continuity care for noncommunicable chronic diseases (NCD), such as
diabetes mellitus (DM). We conducted two proof-of-concept studies to further the understanding of the status of NCD programs
and the feasibility and effectiveness of adapting HIV program-related tools and systems for patients with DM. In Swaziland, a
rapid assessment illustrated gaps in the approaches used to support DM services at 15 health facilities, despite the existence of
chronic care systems at HIV clinics in the same hospitals, health centers, and clinics. In Ethiopia, a pilot study found similar gaps
in DM services at baseline and illustrated the potential to rapidly improve the quality of care and treatment for DM by adapting
HIV-specific policies, systems, and tools.
1. Introduction
HIV/AIDS is the leading cause of death among adults in sub-
Saharan Africa (SSA), but the burden of noncommunicable
chronic diseases (NCD) is high and growing [1]. The
regional prevalence of diabetes mellitus (DM), for example,
is expected to double between 2010 and 2030, when 28
million people in SSA are projected to be living with DM
[2]. In addition to DM-specific morbidity andmortality, dia-
betes contributes to the burden of other noncommunicable
diseases (e.g., renal and cardiovascular disease) as well as
communicable diseases (e.g., pneumonia and tuberculosis),
further increasing its impact on public health [3]. In 2010,
6% of total mortality in SSA was attributable to DM [4].
Unfortunately, access to prevention, care, and treatment
services for NCD like DM remains out of reach for most
in SSA, and health systems in lower-income countries are
rarely designed to provide the continuity services required
to effectively identify patients at risk, engage them in care,
and retain them for the course of what is usually life-long
treatment. The International Diabetes Federation estimates
that 78% of those with DM in SSA remain undiagnosed [5],
a consequence of limited access to trained health workers and
laboratory testing as well as limited awareness of DM and
its risk factors. Although there have been several promising
pilot studies of nurse-led DM management and other
innovations [6–9], glycemic control tends to be suboptimal
for those enrolled in care, even at specialized treatment
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Table 1: Disease burden in Swaziland and Ethiopia.
Ethiopia Swaziland
Population (2010)1 82,949,541 1,186,056
Income group (World Bank classification) Low Lower middle
Total health expenditure/capita ($USD)2 $15 $156
Life expectancy at birth (2009)2 54 years 49 years
HIV prevalence2 2.1% 25.9%
DM prevalence3 3.45% 2.36%
Total NCD deaths (000s)1 161.4 (males), 176.9 (females) 2.5 (males), 2.4 (females)
Age-standardized death rate from CVD and DM (per 100,000)1 486.1 (males), 530.3 (females) 558.2 (males), 441.9 (females)
% of all deaths attributable to NCDs1 35% 28%
NCD branch/unit/department in MOH?1 Yes Yes
National diabetes plan/program?1 No No
1
WHO. Noncommunicable Disease Country Profiles 2011. Available at: http://www.who.int/nmh/publications/ncd profiles2011/en/index.html (Accessed 8
March 2012).
2WHO Global Health Observatory. Available at: http://apps.who.int/ghodata/ (Accessed 8 March 2012).
3International Diabetes Federation. Diabetes Atlas 5th edition. International Diabetes Federation. Brussels; 2011. Available at http://www.idf.org/diabetesatlas
(Accessed 8 March 2012).
centers [10, 11]. Out-of-pocket costs for medicines, labora-
tory tests, and transportation create formidable barriers to
adherence, as do stock-outs of drugs and supplies and the
absence of effective systems to support chronic care [4, 12].
There is a pressing need to expand the coverage, quality,
and equity of services for DM and other NCD in SSA.
Although often overlooked in this context, HIV programs
are the first large-scale chronic disease initiatives in the
region and, as such, an important resource for those
hoping to expand NCD prevention, care, and treatment. In
country after country, Ministries of Health—with support
from donors and partners—have developed locally owned,
contextually appropriate chronic care programs for HIV.
With the expansion of HIV care and treatment programs,
health systems that had previously delivered only episodic
acute care services have been redesigned to provide longitu-
dinal services and lifetime care for people living with HIV
(PLWH). In some cases, these changes represent innovations
and new approaches, while in others they represent the
availability of unprecedented levels of funding to implement
time-tested strategies.
From the health system and program management
perspectives, chronic diseases have much in common with
one another, whether they are communicable or noncommu-
nicable. For example, both DM and HIV require laboratory
diagnosis, daily medication (in some stages), and life-long
self-management, including behavior changes. Symptoms of
both diseases wax and wane over time, requiring ongoing
clinical and laboratory monitoring, patient education, and
adherence support. In addition, both HIV and DM may
cluster within families and households, the former due
to sexual and perinatal transmission and the latter due
to shared genetic and environmental risk factors in some
settings [4, 13]. There are also key differences, including the
characteristic age groups affected, dissimilar stigma attached
to the two conditions, and disease-specific mortality rates.
Nonetheless, based on the key similarities, our hypothesis
is that the systems, tools, and implementation strategies
developed to provide continuity care for HIV in SSA can be
rapidly, efficiently, and effectively utilized to support services
for DM and other chronic NCD [14–17].
ICAP at Columbia University supports Ministries of
Health and other local organizations in 21 countries, includ-
ing 16 in sub-Saharan Africa. ICAP provides a wide range
of HIV-related technical and infrastructure support to more
than 2,500 health facilities, enabling the provision of quality
comprehensive HIV/AIDS prevention, care, and treatment
services. Recognizing the potential to build upon ICAP’s
experience to support continuity care programs for a range of
chronic diseases, we embarked on two pilot studies to further
the understanding of the status of NCD services and the
feasibility and effectiveness of adapting HIV program-related
tools and systems for patients with DM. In Swaziland, we
compared systems and services for HIV and DM at 15 health
facilities in order to identify opportunities for experience
sharing and diffusion of innovations. In Ethiopia, a multi-
component intervention adapted the approaches used in
HIV clinic to enhance diabetes services at an urban referral
hospital (see Table 1 for additional context).
2. Materials and Methods
2.1. DM Program Assessment in Swaziland. In consultation
with the Swaziland Ministry of Health (MOH), an analysis
of NCD services was developed, using DM as an example.
The study had three components: site assessments, chart
review, and health care worker questionnaires. The study was
approved by the MOH, and ethical approvals were obtained
from the Columbia University Institutional Review Board
and the Swaziland Scientific and Ethics Committee. Data
were entered into a Microsoft ACCESS database, which was
used for the relevant analyses.
Site Assessments. An existing HIV-specific site assessment
tool [18] was adapted for DM, feedback was obtained
from local clinicians, and the revised tool was piloted at
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a rural health facility. The resultant site survey tool used
a checklist and rating scales to consistently and objectively
describe site-level implementation of DM-specific health
systems and services. Fifty-nine questions enabled the sys-
tematic description of six domains, including (1) program
management; (2) organization of services and clinical care;
(3) monitoring, evaluation, and medical records systems; (4)
human resources; (5) laboratory capacity; and (6) pharmacy
capacity. A convenience sample of 15 ICAP-supported health
facilities from three of the four regions in Swaziland was
selected for the survey: three of the country’s six hospitals,
three of five health centers, and nine of 202 health clinics.
Eleven of the facilities were public and four were supported
by not-for-profit nongovernmental organizations. All of the
facilities had functioning HIV care and treatment clinics at
the time of the site assessment. With the permission of MOH
and the appropriate facility leadership, ICAP research staff
completed the structured survey for each of the 15 facilities
between June and August 2010, visiting relevant wards and
clinics, interviewing site-level staff, and observing continuity
care services for adults with DM.
Chart Review. A chart abstraction tool was developed to col-
lect information from outpatient records, including clinical,
laboratory, pharmacy, and counseling services recognized to
be important for DM management. Only four of the 15
facilities maintained on-site medical records for outpatients
with NCD, so the decision was made to abstract charts at
the study site with the most available charts—Mbabane Gov-
ernment Hospital—recognizing that it is not representative
of health facilities in Swaziland. The charts of 100 diabetic
patients were sampled using a random number generator
and reviewed by study staff.
Clinician Surveys. A questionnaire was developed to elicit
the attitudes and practices of health care workers regarding
programs and systems for DM. The written survey was self-
administered by 72 clinicians (11 doctors, 43 nurses, 15
nurse assistants, and 3 individuals from other cadres) at three
health facilities. This nonrandom sample represents approx-
imately 17% of the physicians, 13% of the nurses, and 11%
of the nursing assistants working at the three sites in 2010.
2.2. Pilot Study in Ethiopia. In consultation with the Federal
Ministry of Health, the Ethiopian Diabetes Association
(EDA), and other stakeholders, a study protocol was devel-
oped and an intervention site was selected. Ethical approvals
were obtained from the Columbia University Institutional
Review Board and the Oromiya Regional Health Bureau in
Ethiopia.
The study design was a single time-series (a baseline as-
sessment, a multicomponent intervention, and a six-month
follow-up assessment) conducted at Adama Hospital, an
urban referral hospital 100 km southeast of Addis Ababa. At
the time of the study, Adama Hospital provided HIV care
to more than 17,000 adults and children, of whom 10,600
had initiated ART. Consistent with other Ethiopian health
facilities, Adama Hospital provides outpatient DM services
within the general outpatient department (OPD) rather than
at a separate diabetes clinic.
The intervention package included strategies, systems,
and tools adapted from Adama Hospital’s HIV program and
applied to DM services in the OPD. Strategies included the
introduction of an “essential package” of key services, the
use of step-by-step protocols, emphasis on family-focused
care and point-of-service diagnosis, and identification of
simple, useful monitoring and evaluation (M&E) indicators.
Systems included appointment systems, clinical mentoring
approaches, and the use of peer educators. Tools included
appointment books, charting tools and flow sheets, job aids,
and logbooks/registers. No new or experimental clinical ser-
vices were introduced: all protocols were consistent with local
guidelines and best practices. No additional support was
provided for medications, laboratory testing, or transporta-
tion, and no new staff were engaged for implementation;
services were provided by existing Adama Hospital clinicians
supported by existing ICAP Ethiopia clinical advisors who
also provided ongoing support for the AdamaHospital’s HIV
clinic.
Baseline Assessment and Six-Month Follow-Up. The baseline
assessment, conducted in the second quarter of 2010,
included systematic observation of DM services in the OPD.
Patient flow was mapped, patient encounters were observed,
and key informant interviews were conducted with hospital
leadership, clinicians, and patients. A chart abstraction tool
was developed and piloted, and the baseline chart review was
conducted for the 261 adult DM patients who had visited
the OPD for DM services within the prior three months.
Chart review and key informant interviews were repeated six
months later. Data were entered into a Microsoft ACCESS
database, which was used for the relevant analyses.
Intervention Package. Following the approach used to sup-
port Adama Hospital’s HIV clinic, an intervention package
was adapted and implemented to support DM services in the
OPD. Clinical equipment was procured (ophthalmoscopes,
sphygmomanometers, and scales); ongoing training and
clinical mentoring of nurses and doctors were provided in
partnership with the EDA; HIV-specific standard operating
protocols and provider support tools (wall posters, pocket
guides, and desktop references) were adapted for DM, as were
HIV-specific charting and health management information
system tools (checklists, flow sheets, standardized forms);
DM appointment books and an appointment system were
introduced; a DM peer educator curriculum was developed,
and training and logistical support for volunteer DM peer
educators was provided; family-focused care and point-of-
service DM testing for patient family members were initi-
ated; simple standardized data were collected with ongoing
feedback to clinicians.
3. Results
3.1. DM Program Assessment in Swaziland. None of the
facilities utilized formal treatment algorithms or identified
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Figure 1: Swaziland chart review: distribution of fasting blood glucose results (n = 100 charts).
a basic “package of care” for DM. In contrast, HIV care
and treatment were supported by national guidelines and
step-by-step algorithms. In DM clinics, on-site medical
records were the exception, not the rule: 4/15 (27%) of the
sites had on-site medical records for DM patients, while
all HIV clinics had on-site medical records and charting
tools. None of the facilities had established appointment
systems, defaulter tracking, adherence support programs,
educational materials, or peer educators for DM, despite
the fact that these services were available for PLWH. HIV
clinics used structured appointment registers printed by
MOH and available nationwide; the DM clinics that kept any
appointment records used ad hoc handwritten notes.
Availability of equipment at DM clinics and drugs for
DM patients was variable. At the time of the assessment,
all the facilities had sphygmomanometers and scales, 80%
had stadiometers/height measures, and only 40% had oph-
thalmoscopes. 100% of facilities reported that aspirin and
thiazide diuretics were “usually or always” available at the
pharmacy, but oral hypoglycemics were “usually or always”
available at only 70% of facilities and less than half of the
facilities “usually or always” had insulin, beta blockers, or
ACE-inhibitors in stock. On-site access to diagnostic tests for
DM was limited. Urine glucose testing was available at 93%
of facilities, but blood glucose levels, creatinine, and total
cholesterol tests were available at only 73%, 53%, and 26%
of facilities, respectively. Two of the 15 facilities (13%) had
functioning electrocardiograms on site. DM patients paid
out of pocket for all medications and laboratory tests, in
contrast to patients attendingHIV clinic for whom drugs and
diagnostic tests were provided at no cost.
The median age of patients randomly selected for chart
review was 56 years; 66% were female. The patients attended
DM clinic fairly regularly, with 60% of patients making more
than 15 documented visits since their initial enrollment.
Most of the patients (81%) had been attending clinic for
more than two years, and 75% had been seen at DM clinic
within the past 6 months. However, only 26% of patients had
optimal DM control, as defined by the International Diabetes
Federation (Figure 1). In addition, 72% of the diabetic
patients had HTN, defined as either a most recent blood
pressure (BP) measurement of systolic BP > 140mmHg
and/or diastolic BP > 90mmHg or at least three documented
prior elevated BP measurements. Within this subgroup, only
23% were normotensive at their most recent visit.
None of the facilities used flow sheets, checklists, or
structured note templates for DM management, in contrast
to many of the HIV clinics in Swaziland. At Mbabane
Government Hospital, all charts had records of at least one
fasting blood glucose measurement and at least one blood
pressure measurement; 68% had weight documented at least
once. Other documentation was scanty; current medications
were documented in 1% of charts, foot exam in 7%, and
fundoscopic exam in 1%. None of the charts reviewed had
documentation of smoking status, medication adherence, or
presence/absence of diabetic complications.
The health care workers who completed the question-
naire indicated that barriers to provision of appropriate
DM care included lack of guidelines and standard operating
protocols, shortages of drugs and equipment, and inadequate
staffing. Health care workers also recognized substantial
barriers to adherence and retention of patients in care,
including the costs of medications and laboratory tests,
transportation barriers, and limited access to patient educa-
tion and counseling services. Of note, 35% of respondents
said that they or a family member had DM.
3.2. Pilot Study in Ethiopia. The median age of DM patients
at Adama Hospital was 47 years (range 18–83 years), 51%
were male, 60% had type 2 DM, and 57% were currently
receiving insulin. Patients had been diagnosed with DM for a
median of 3 years (range 1–23 years) and had been followed
at Adama Hospital for a median of 2 years (range 0–22
years). 21% had been previously hospitalized for DM, 5%
had a history of foot ulcer, 20% had been diagnosed with
peripheral neuropathy, 8% had reported visual impairment,
and 2% had at least one amputation.
At baseline, no algorithms or standard operating proto-
cols were used to support DM care; clinic staff reported that
each individual clinician drew upon his/her training to deter-
mine optimal clinical management on a case-by-case basis.
Of 45 clinicians surveyed (5 doctors, 37 nurses, and 3 other),
47% had received their degree or certification more than 10
years ago, and only 16% reported additional training in DM











































































Figure 2: Ethiopia pilot study services offered and documented at least once in the past 3 visits—before and after intervention.
management since graduation. (Of note, 22% of clinicians
reported having at least one family member with DM).
In the 260 charts reviewed, key clinical services were
rarely documented at baseline. Although 80% of patients
had a blood pressure (BP) measurement documented at least
once, only 21% had ever had a documented fundoscopic
exam. Foot exam had ever been documented in 10% of
patients, and only 1% had a documented weight in their
chart. When review was confined to the patients’ three most
recent visits, these rates were still lower (Figure 2).
Follow-up chart review was conducted six months after
the intervention was initiated. Figure 2 shows baseline and
follow-up data on documentation of services within the
patients’ past three visits. The percentage of charts in which
patient weight was documented at least once in the past three
visits increased from 2% to 82%. Documentation of BP rose
from 45% to 80%. Documentation of fundoscopic exam,
foot exam, and neurologic exam rose from 1% to 50%, 3% to
81%, and 3% to 56%, respectively. Adherence assessment was
documented in 2% of charts prior to the intervention and
77% after the intervention; record of the next appointment
date rose from 17% to 81%. Key informant interviews
and focus group discussions indicated increased patient
satisfaction with clinic services.
4. Discussion
The program assessment identified significant gaps in the
strategies, systems, and tools used to support DM services at
15 health facilities in Swaziland, as well as suboptimal control
of hyperglycemia and hypertension amongst patients with
DM at Mbabane Government Hospital. Although effective
DM care requires longitudinal services and chronic care
systems, diabetic patients in Swaziland did not have access to
the types of interventions needed for appropriate manage-
ment of their disease. This contrasted with the presence of
functional chronic care programs developed for HIV situated
within the same health care facilities. In Ethiopia, the rapid
“proof-of-concept” study found similar gaps in DM services
at baseline and illustrated the potential to swiftly improve
the quality of care and treatment for DM by adapting HIV-
specific strategies, systems, and tools. There was a marked
increase in documented service delivery and significant
improvements in standards of care with no added staff.
These studies were intended to be hypothesis generating.
The Ethiopia pilot study measured process indicators rather
than clinical outcomes and did not include a comparison
site; it is possible that alternate interventions not based on
HIV programs could have achieved a similar effect. Although
clinicians reported that the introduction of new systems was
facilitated by the fact of local ownership—that the same
systems and tools were already being used in the hospital’s
HIV clinic—the magnitude of this effect was not quantified.
In Swaziland, site assessments and clinician surveys used
nonrandom samples; the results may not be representative
of health facilities and health providers nationwide.
There are multiple ways in which to build upon the
lessons and resources of HIV programs when working to
expand and enhance DM and NCD services, and no single
approach is likely to work in all settings. In some countries,
integration of chronic disease services for HIV and NCDs
at the point of care may be an effective approach [18]. In
other settings, as in Ethiopia, this may be neither feasible
nor desirable. A continuum of approaches is available to
implementers and policy makers, ranging from parallel
“side-by-side” services to complete integration of chronic
disease care and treatment. The intermediate approach is one
in which clinical services are not merged or integrated, but
the systems behind them are shared, including guidelines,
training, procurement of drugs and supplies, laboratory
systems, and monitoring and evaluation strategies.
5. Conclusions
In summary, the pilot studies described in this paper are
among the few to document the potential of leveraging
lessons learned from HIV programs to support NCD care
and treatment services in sub-Saharan Africa. The findings
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suggest that countries which have successfully scaled up HIV
services have already learned profound lessons about the
delivery of chronic care. Using these locally owned and con-
textually appropriate resources may be an efficient and effec-
tive way to “jumpstart” NCD programs and to strengthen
health systems to support longitudinal services for all. No
one approach will be right for all countries and contexts,
and funds are needed to support larger, controlled studies to
elucidate the impact and costs of using this strategy.
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